These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 8780431

  • 21. Obsessive-compulsive disorder: a double-blind, placebo-controlled trial of clomipramine in 27 patients.
    Jenike MA, Baer L, Summergrad P, Weilburg JB, Holland A, Seymour R.
    Am J Psychiatry; 1989 Oct; 146(10):1328-30. PubMed ID: 2675643
    [Abstract] [Full Text] [Related]

  • 22. Double-blind study of adjuvant buspirone for fluoxetine-treated patients with obsessive-compulsive disorder.
    Grady TA, Pigott TA, L'Heureux F, Hill JL, Bernstein SE, Murphy DL.
    Am J Psychiatry; 1993 May; 150(5):819-21. PubMed ID: 8480832
    [Abstract] [Full Text] [Related]

  • 23. Effect of inositol on bulimia nervosa and binge eating.
    Gelber D, Levine J, Belmaker RH.
    Int J Eat Disord; 2001 Apr; 29(3):345-8. PubMed ID: 11262515
    [Abstract] [Full Text] [Related]

  • 24. Compulsive exhibitionism successfully treated with fluvoxamine: a controlled case study.
    Zohar J, Kaplan Z, Benjamin J.
    J Clin Psychiatry; 1994 Mar; 55(3):86-8. PubMed ID: 8071253
    [Abstract] [Full Text] [Related]

  • 25. Controlled comparison of buspirone and clomipramine in obsessive-compulsive disorder.
    Pato MT, Pigott TA, Hill JL, Grover GN, Bernstein S, Murphy DL.
    Am J Psychiatry; 1991 Jan; 148(1):127-9. PubMed ID: 1984696
    [Abstract] [Full Text] [Related]

  • 26. Clomipramine and obsessive compulsive disorder: a placebo-controlled double-blind study of 32 patients.
    Greist JH, Jefferson JW, Rosenfeld R, Gutzmann LD, March JS, Barklage NE.
    J Clin Psychiatry; 1990 Jul; 51(7):292-7. PubMed ID: 2195006
    [Abstract] [Full Text] [Related]

  • 27. The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder.
    McDougle CJ, Goodman WK, Leckman JF, Barr LC, Heninger GR, Price LH.
    J Clin Psychopharmacol; 1993 Oct; 13(5):354-8. PubMed ID: 8227493
    [Abstract] [Full Text] [Related]

  • 28. Inositol versus placebo augmentation of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder: a double-blind cross-over study.
    Fux M, Benjamin J, Belmaker RH.
    Int J Neuropsychopharmacol; 1999 Sep; 2(3):193-195. PubMed ID: 11281989
    [Abstract] [Full Text] [Related]

  • 29. Absence of placebo response in obsessive-compulsive disorder.
    Mavissakalian MR, Jones B, Olson S.
    J Nerv Ment Dis; 1990 Apr; 178(4):268-70. PubMed ID: 2319236
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Pentagastrin has panic-inducing properties in obsessive compulsive disorder.
    de Leeuw AS, Den Boer JA, Slaap BR, Westenberg HG.
    Psychopharmacology (Berl); 1996 Aug; 126(4):339-44. PubMed ID: 8878350
    [Abstract] [Full Text] [Related]

  • 35. Inositol in the treatment of trichotillomania and compulsive skin picking.
    Seedat S, Stein DJ, Harvey BH.
    J Clin Psychiatry; 2001 Jan; 62(1):60-1. PubMed ID: 11235935
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. What Future Role Might N-Acetyl-Cysteine Have in the Treatment of Obsessive Compulsive and Grooming Disorders?: A Systematic Review.
    Smith L, Tracy DK, Giaroli G.
    J Clin Psychopharmacol; 2016 Feb; 36(1):57-62. PubMed ID: 26629962
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.